RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma

RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma

Abstract Drugs that mobilise the immune system against cancer are dramatically improving care for many people. Dying cancer cells play an active role in inducing anti‐tumour immunity but not every form of death can elicit an immune response. Moreover, resistance to apoptosis is a major problem in ca...

Full description

Bibliographic Details
Main Authors: Henry G Smith, Kunzah Jamal, Jasbani HS Dayal, Tencho Tenev, Joan Kyula‐Currie, Naomi Guppy, Patrycja Gazinska, Victoria Roulstone, Gianmaria Liccardi, Emma Davies, Ioannis Roxanis, Alan A Melcher, Andrew J Hayes, Gareth J Inman, Kevin J Harrington, Pascal Meier
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:EMBO Molecular Medicine
Subjects:
apoptosis
RIPK1
SMAC mimetics
soft‐tissue sarcoma
TNF
Online Access:https://doi.org/10.15252/emmm.201910979

Internet

https://doi.org/10.15252/emmm.201910979

Similar Items